Skip to main content
. 2015 Mar 25;10(3):e0122034. doi: 10.1371/journal.pone.0122034

Table 3. Association between class of antibiotic and number and timing of antibiotic prescriptions in pregnancy with cerebral palsy and/or epilepsy in childhood.

Number (%) of women Number of children with cerebral palsy and/or epilepsy Follow-up in child-years-at-risk (CYAR) Incidence rate of cerebral palsy and/or epilepsy per 100,000 CYAR (95% confidence interval) Unadjusted hazard ratio (95% confidence interval) Adjusted hazard ratio (95% confidence interval)
TYPE—Group of antibiotic prescribed (n = 41,276 women with single prescriptions for most commonly prescribed antibiotics in pregnancy) Penicillins 27,577 (66.8%) 156 108,630 143.6 (122.8, 168.0) [Ref] [Ref]
Cephalosporins, carbapenems, and other beta-lactams 7,740 (18.8%) 40 28,327 141.2 (103.6, 192.5) 0.96 (0.68, 1.36) 0.99 (0.69, 1.41)
Sulphonamides and trimethoprim 1,375 (3.3%) 7 5,169 135.4 (64.6, 284.1) 0.93 (0.45, 1.95) 0.89 (0.43, 1.85)
Nitrofurantoin 802 (1.0%) 6 2,900 206.9 (93.0, 460.5) 1.42 (0.65, 3.13) 1.31 (0.58, 2.92)
Metronidazole and tinidazole 1,033 (2.5%) 9 3,987 225.7 (117.4, 433.8) 1.56 (0.82, 2.99) 1.5 (0.78, 2.88)
Macrolides 2,749 (6.7%) 28 11,012 254.3 (175.6, 368.3) 1.77** (1.18, 2.68) 1.78** (1.18, 2.69)
NUMBER—No. antibiotic prescriptions (n = 195,909 women with any number of prescriptions) 0 131,286 (67.0%) 739 514,030 143.8 (133.8, 154.5) [Ref] [Ref]
1 42,065 (21.5%) 252 163,203 154.4 (136.5, 174.7) 1.07 (0.92, 1.25) 0.98 (0.84, 1.14)
2 14,166 (7.2%) 96 54,385 176.5 (144.5, 215.6) 1.22 (1.00, 1.50) 1.04 (0.84, 1.29)
3+ 8,392 (4.3%) 83 31,792 261.1 (210.5, 323.7) 1.80*** (1.41, 2.31) 1.40* (1.07, 1.83)
TIMING—by lunar month of antibiotic prescription (n = 42,065 women with single prescriptions) M1 4,182 (9.9%) 24 16,452 145.9 (97.8, 217.6) [Ref] [Ref]
M2 3,689 (8.8%) 18 13,888 129.6 (81.7, 205.7) 0.88 (0.47, 1.65) 0.89 (0.47, 1.67)
M3 3,655 (8.7%) 22 13,591 161.9 (106.6, 245.8) 1.09 (0.63, 1.90) 1.12 (0.64, 1.94)
M4 4,387 (10.4%) 23 16,746 137.3 (91.3, 206.7) 0.93 (0.51, 1.73) 0.95 (0.51, 1.76)
M5 4,356 (10.4%) 19 16,819 113 (72.1, 177.1) 0.77 (0.43, 1.38) 0.78 (0.43, 1.42)
M6 4,227 (10.0%) 31 16,345 189.7 (133.4, 269.7) 1.3 (0.76, 2.22) 1.3 (0.75, 2.23)
M7 4,246 (10.1%) 31 16,757 185 (130.1, 263.1) 1.27 (0.76, 2.13) 1.29 (0.77, 2.16)
M8 4,222 (10.0%) 35 16,580 211.1 (151.7, 294.0) 1.45 (0.89, 2.34) 1.45 (0.89, 2.36)
M9 4,434 (10.5%) 26 17,515 148.4 (101.1, 218.0) 1.02 (0.58, 1.79) 1.03 (0.58, 1.82)
M10 4,667 (11.1%) 23 18,511 124.3 (82.6, 187.0) 0.85 (0.48, 1.53) 0.87 (0.48, 1.56)

* p<0.05

** p<0.01

*** p<0.001

† Analyses on TYPE and TIMING of prescription—Cox regression models adjusted for year of delivery, Townsend quintile, and potentially neurologically-damaging infection recorded during pregnancy.

‡ Analysis on NUMBER of prescriptions—Cox regression model adjusted for maternal age, Townsend quintile, year of delivery, smoking/tobacco use, alcohol problems, obesity, illicit drug use, treatment of chronic medical conditions and potentially neurologically-damaging infection during pregnancy.